Skip to main content

Table 2 The lytic activity of phage ZCPA1 against 50 clinical isolates of P. aeruginosa (P.s 1 to P.s 50)

From: Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model

Bacterial strain

ZCPA1

Bacterial strain

ZCPA1

Bacterial strain

ZCPA1

Bacterial Strain

ZCPA1

Bacterial strain

ZCPA1

P. s 1

+

P. s 11

−

P. s 21

+

P. s 31

+

P.s 41

−

P. s 2

−

P. s 12

+

P. s 22

+

P. s 32

+

P.s 42

−

P. s 3

+

P. s 13

+

P. s 23

+

P. s 33

+

P.s 43

−

P. s 4

−

P. s 14

−

P. s 24

+

P. s 34

+

P.s 44

−

P. s 5

−

P. s 15

+

P. s 25

+

P. s 35

−

P.s 45

−

P. s 6

−

P. s 16

+

P. s 26

+

P. s 36

+

P.s 46

−

P. s 7

−

P. s 17

+

P. s 27

+

P. s 37

+

P.s 47

−

P. s 8

−

P. s 18

+

P. s 28

+

P. s 38

+

P.s 48

−

P. s 9

−

P. s 19

+

P. s 29

+

P.s 39

+

P.s 49

−

P. s 10

−

P. s 20

+

P. s 30

+

P.s 40

−

P.s 50

−

  1. + indicates lysis, and − indicates no lysis